Systemic Inflammatory Proteomic Biomarkers in Atopic Dermatitis: Exploring Potential Indicators for Disease Severity

Area of Science:

• Immunology
• Dermatology
• Proteomics

Background:

• Atopic dermatitis (AD) is a chronic inflammatory skin condition influenced by genetics, immune responses, and environmental factors.
• Understanding AD's inflammatory pathways is crucial for comprehending its pathogenesis.
• This study investigated proteins associated with AD inflammation and their correlation with clinical severity.

Purpose of the Study:

• To explore the spectrum of proteins involved in AD-related inflammation.
• To identify systemic proteomic biomarkers associated with AD severity.
• To enhance the understanding of AD complexity and potential management.

Main Methods:

• Blood samples from 48 AD patients and 48 healthy controls were analyzed using the Proximity Extension Assay (Olink).
• Differentially expressed proteins (DEPs) between groups were identified.
• Pearson correlation analysis was used to link proteomic biomarkers with AD severity.

Main Results:

• 29 proteins were significantly upregulated, and 2 were downregulated in AD patients compared to controls.
• MCP-4, IL-18, MCP-3, TNFRSF9, and IL-17C were the top 5 DEPs correlated with AD severity.
• These proteins represent potential systemic biomarkers for assessing AD clinical status.

Conclusions:

• The study highlights a network of inflammatory proteins implicated in AD.
• Identified systemic inflammatory proteins may serve as valuable indicators of AD severity.
• Findings contribute to a deeper understanding of AD complexity and inform potential therapeutic strategies.